RDF of MGI data
pubmed
Xunshan. Ding, et.al., βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism., Cell metabolism, 2012, 16
http://rdf.ncbi.nlm.nih.gov/pubmed/22958921
Xunshan. Ding, et.al., βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism., Cell metabolism, 2012, 16(pubmed)
ダウンロード
SPARQL
足あと
問い合わせ
URI表示モード
Xunshan. Ding, et.al., βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism., Cell metabolism, 2012, 16
pubmed
allele
http://purl.org/net/cito/citesAsAuthority
Klb<tm1.1Sakl>
http://metadb.riken.jp/db/mgi_rdf/MGI:5446140
Klb<tm1.2Sakl>
http://metadb.riken.jp/db/mgi_rdf/MGI:5446141
表現型アノテーション
http://purl.org/net/cito/citesAsAuthority
abnormal liver morphology_Klb<tm1.2Sakl>/Klb<tm1.2Sakl>,Tg(Apoe-Fgf21)1Sakl/0
http://metadb.riken.jp/0000598I129129S4SvJaeSorC57BL6Klbtm12SaklKlbtm12SaklTgApoeFgf211Sakl0Klbtm12SaklTgApoeFgf211Sakl
decreased body weight_Klb<tm1.2Sakl>/Klb<+>,Tg(Apoe-Fgf21)1Sakl/0
http://metadb.riken.jp/0001262I129129S4SvJaeSorC57BL6Klbtm12SaklKlbTgApoeFgf211Sakl0KlbKlbtm12SaklTgApoeFgf211Sakl
decreased body weight_Klb<tm1.2Sakl>/Klb<tm1.2Sakl>
http://metadb.riken.jp/0001262I129129S4SvJaeSorC57BL6Klbtm12SaklKlbtm12SaklKlbtm12Sakl
decreased body weight_Klb<tm1.2Sakl>/Klb<tm1.2Sakl>,Tg(Apoe-Fgf21)1Sakl/0
http://metadb.riken.jp/0001262I129129S4SvJaeSorC57BL6Klbtm12SaklKlbtm12SaklTgApoeFgf211Sakl0Klbtm12SaklTgApoeFgf211Sakl
abnormal eating behavior_Klb<tm1.2Sakl>/Klb<+>,Tg(Apoe-Fgf21)1Sakl/0
http://metadb.riken.jp/0001431I129129S4SvJaeSorC57BL6Klbtm12SaklKlbTgApoeFgf211Sakl0KlbKlbtm12SaklTgApoeFgf211Sakl
abnormal glucose homeostasis_Klb<tm1.2Sakl>/Klb<tm1.2Sakl>
http://metadb.riken.jp/0002078I129129S4SvJaeSorC57BL6Klbtm12SaklKlbtm12SaklKlbtm12Sakl
他
28
件を見る
abnormal glucose homeostasis_Klb<tm1.2Sakl>/Klb<tm1.2Sakl>,Tg(Apoe-Fgf21)1Sakl/0
http://metadb.riken.jp/0002078I129129S4SvJaeSorC57BL6Klbtm12SaklKlbtm12SaklTgApoeFgf211Sakl0Klbtm12SaklTgApoeFgf211Sakl
abnormal glucose homeostasis_Klb<tm1.1Sakl>/Klb<tm1.1Sakl>,Tg(Fabp4-cre)1Rev/0
http://metadb.riken.jp/0002078I129C57BL6SJLKlbtm11SaklKlbtm11SaklTgFabp4cre1Rev0TgFabp4cre1RevKlbtm11Sakl
decreased susceptibility to hepatic steatosis_Klb<tm1.2Sakl>/Klb<+>,Tg(Apoe-Fgf21)1Sakl/0
http://metadb.riken.jp/0002310I129129S4SvJaeSorC57BL6Klbtm12SaklKlbTgApoeFgf211Sakl0KlbKlbtm12SaklTgApoeFgf211Sakl
decreased circulating triglyceride level_Klb<tm1.2Sakl>/Klb<+>,Tg(Apoe-Fgf21)1Sakl/0
http://metadb.riken.jp/0002644I129129S4SvJaeSorC57BL6Klbtm12SaklKlbTgApoeFgf211Sakl0KlbKlbtm12SaklTgApoeFgf211Sakl
decreased circulating triglyceride level_Klb<tm1.2Sakl>/Klb<tm1.2Sakl>
http://metadb.riken.jp/0002644I129129S4SvJaeSorC57BL6Klbtm12SaklKlbtm12SaklKlbtm12Sakl
decreased circulating free fatty acid level_Klb<tm1.2Sakl>/Klb<+>,Tg(Apoe-Fgf21)1Sakl/0
http://metadb.riken.jp/0002702I129129S4SvJaeSorC57BL6Klbtm12SaklKlbTgApoeFgf211Sakl0KlbKlbtm12SaklTgApoeFgf211Sakl
decreased circulating free fatty acid level_Klb<tm1.2Sakl>/Klb<tm1.2Sakl>,Tg(Apoe-Fgf21)1Sakl/0
http://metadb.riken.jp/0002702I129129S4SvJaeSorC57BL6Klbtm12SaklKlbtm12SaklTgApoeFgf211Sakl0Klbtm12SaklTgApoeFgf211Sakl
decreased circulating insulin level_Klb<tm1.2Sakl>/Klb<+>,Tg(Apoe-Fgf21)1Sakl/0
http://metadb.riken.jp/0002727I129129S4SvJaeSorC57BL6Klbtm12SaklKlbTgApoeFgf211Sakl0KlbKlbtm12SaklTgApoeFgf211Sakl
short tibia_Klb<tm1.2Sakl>/Klb<+>,Tg(Apoe-Fgf21)1Sakl/0
http://metadb.riken.jp/0002764I129129S4SvJaeSorC57BL6Klbtm12SaklKlbTgApoeFgf211Sakl0KlbKlbtm12SaklTgApoeFgf211Sakl
short tibia_Klb<tm1.2Sakl>/Klb<tm1.2Sakl>,Tg(Apoe-Fgf21)1Sakl/0
http://metadb.riken.jp/0002764I129129S4SvJaeSorC57BL6Klbtm12SaklKlbtm12SaklTgApoeFgf211Sakl0Klbtm12SaklTgApoeFgf211Sakl
increased insulin sensitivity_Klb<tm1.2Sakl>/Klb<+>,Tg(Apoe-Fgf21)1Sakl/0
http://metadb.riken.jp/0002891I129129S4SvJaeSorC57BL6Klbtm12SaklKlbTgApoeFgf211Sakl0KlbKlbtm12SaklTgApoeFgf211Sakl
increased insulin sensitivity_Klb<tm1.1Sakl>/Klb<tm1.1Sakl>,Tg(Fabp4-cre)1Rev/0
http://metadb.riken.jp/0002891I129C57BL6SJLKlbtm11SaklKlbtm11SaklTgFabp4cre1Rev0TgFabp4cre1RevKlbtm11Sakl
decreased liver weight_Klb<tm1.2Sakl>/Klb<+>,Tg(Apoe-Fgf21)1Sakl/0
http://metadb.riken.jp/0003402I129129S4SvJaeSorC57BL6Klbtm12SaklKlbTgApoeFgf211Sakl0KlbKlbtm12SaklTgApoeFgf211Sakl
abnormal lean body mass_Klb<tm1.2Sakl>/Klb<tm1.2Sakl>,Tg(Apoe-Fgf21)1Sakl/0
http://metadb.riken.jp/0003959I129129S4SvJaeSorC57BL6Klbtm12SaklKlbtm12SaklTgApoeFgf211Sakl0Klbtm12SaklTgApoeFgf211Sakl
increased lean body mass_Klb<tm1.2Sakl>/Klb<+>,Tg(Apoe-Fgf21)1Sakl/0
http://metadb.riken.jp/0003960I129129S4SvJaeSorC57BL6Klbtm12SaklKlbTgApoeFgf211Sakl0KlbKlbtm12SaklTgApoeFgf211Sakl
increased adiponectin level_Klb<tm1.2Sakl>/Klb<+>,Tg(Apoe-Fgf21)1Sakl/0
http://metadb.riken.jp/0004892I129129S4SvJaeSorC57BL6Klbtm12SaklKlbTgApoeFgf211Sakl0KlbKlbtm12SaklTgApoeFgf211Sakl
decreased circulating cholesterol level_Klb<tm1.2Sakl>/Klb<+>,Tg(Apoe-Fgf21)1Sakl/0
http://metadb.riken.jp/0005179I129129S4SvJaeSorC57BL6Klbtm12SaklKlbTgApoeFgf211Sakl0KlbKlbtm12SaklTgApoeFgf211Sakl
improved glucose tolerance_Klb<tm1.2Sakl>/Klb<+>,Tg(Apoe-Fgf21)1Sakl/0
http://metadb.riken.jp/0005292I129129S4SvJaeSorC57BL6Klbtm12SaklKlbTgApoeFgf211Sakl0KlbKlbtm12SaklTgApoeFgf211Sakl
abnormal food intake_Klb<tm1.2Sakl>/Klb<tm1.2Sakl>,Tg(Apoe-Fgf21)1Sakl/0
http://metadb.riken.jp/0005449I129129S4SvJaeSorC57BL6Klbtm12SaklKlbtm12SaklTgApoeFgf211Sakl0Klbtm12SaklTgApoeFgf211Sakl
abnormal percent body fat/body weight_Klb<tm1.2Sakl>/Klb<tm1.2Sakl>,Tg(Apoe-Fgf21)1Sakl/0
http://metadb.riken.jp/0005457I129129S4SvJaeSorC57BL6Klbtm12SaklKlbtm12SaklTgApoeFgf211Sakl0Klbtm12SaklTgApoeFgf211Sakl
decreased percent body fat/body weight_Klb<tm1.2Sakl>/Klb<+>,Tg(Apoe-Fgf21)1Sakl/0
http://metadb.riken.jp/0005459I129129S4SvJaeSorC57BL6Klbtm12SaklKlbTgApoeFgf211Sakl0KlbKlbtm12SaklTgApoeFgf211Sakl
decreased circulating glucose level_Klb<tm1.2Sakl>/Klb<+>,Tg(Apoe-Fgf21)1Sakl/0
http://metadb.riken.jp/0005560I129129S4SvJaeSorC57BL6Klbtm12SaklKlbTgApoeFgf211Sakl0KlbKlbtm12SaklTgApoeFgf211Sakl
abnormal adipose tissue physiology_Klb<tm1.1Sakl>/Klb<tm1.1Sakl>,Tg(Fabp4-cre)1Rev/0
http://metadb.riken.jp/0005666I129C57BL6SJLKlbtm11SaklKlbtm11SaklTgFabp4cre1Rev0TgFabp4cre1RevKlbtm11Sakl
decreased circulating leptin level_Klb<tm1.2Sakl>/Klb<+>,Tg(Apoe-Fgf21)1Sakl/0
http://metadb.riken.jp/0005668I129129S4SvJaeSorC57BL6Klbtm12SaklKlbTgApoeFgf211Sakl0KlbKlbtm12SaklTgApoeFgf211Sakl
decreased liver triglyceride level_Klb<tm1.2Sakl>/Klb<+>,Tg(Apoe-Fgf21)1Sakl/0
http://metadb.riken.jp/0009356I129129S4SvJaeSorC57BL6Klbtm12SaklKlbTgApoeFgf211Sakl0KlbKlbtm12SaklTgApoeFgf211Sakl
abnormal blood homeostasis_Klb<tm1.2Sakl>/Klb<tm1.2Sakl>,Tg(Apoe-Fgf21)1Sakl/0
http://metadb.riken.jp/0009642I129129S4SvJaeSorC57BL6Klbtm12SaklKlbtm12SaklTgApoeFgf211Sakl0Klbtm12SaklTgApoeFgf211Sakl
decreased liver cholesterol level_Klb<tm1.2Sakl>/Klb<+>,Tg(Apoe-Fgf21)1Sakl/0
http://metadb.riken.jp/0010026I129129S4SvJaeSorC57BL6Klbtm12SaklKlbTgApoeFgf211Sakl0KlbKlbtm12SaklTgApoeFgf211Sakl
decreased susceptibility to weight gain_Klb<tm1.2Sakl>/Klb<+>,Tg(Apoe-Fgf21)1Sakl/0
http://metadb.riken.jp/0010182I129129S4SvJaeSorC57BL6Klbtm12SaklKlbTgApoeFgf211Sakl0KlbKlbtm12SaklTgApoeFgf211Sakl
class
http://purl.org/net/cito/citesAsAuthority
Klb<tm1.1Sakl>
http://metadb.riken.jp/db/mgi_rdf/MGI:5446140
Klb<tm1.2Sakl>
http://metadb.riken.jp/db/mgi_rdf/MGI:5446141
お問い合わせ
システムのお問い合わせ
画像
足跡